InvestorsHub Logo
Followers 9
Posts 421
Boards Moderated 0
Alias Born 07/22/2016

Re: None

Thursday, 08/11/2016 7:27:00 PM

Thursday, August 11, 2016 7:27:00 PM

Post# of 7234
The more I read about the clinical hold on Pacritinib, likely an artefact of crossover trial. Hopefully, when Phase 3 results for second trial are published this quarter this will resolve this and we will see $1 minimun.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.